Outset Medical, Inc.
NASDAQ:OM
1.1 (USD) • At close January 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 28.666 | 27.388 | 28.168 | 30.507 | 30.362 | 36.04 | 33.467 | 32.007 | 27.761 | 25.057 | 30.55 | 28.152 | 26.318 | 25.216 | 22.916 | 17.247 | 13.756 | 11.742 | 7.19 | 7.085 | 2.63 | 2.872 | 2.491 |
| Cost of Revenue
| 18.846 | 17.606 | 19.953 | 22.795 | 23.205 | 28.337 | 27.039 | 26.734 | 23.425 | 21.275 | 26.108 | 24.831 | 23.372 | 24.164 | 22.627 | 16.83 | 18.882 | 16.506 | 10.754 | 9.865 | 7.924 | 7.342 | 7.749 |
| Gross Profit
| 9.82 | 9.782 | 8.215 | 7.712 | 7.157 | 7.703 | 6.428 | 5.273 | 4.336 | 3.782 | 4.442 | 3.321 | 2.946 | 1.052 | 0.289 | 0.417 | -5.126 | -4.764 | -3.564 | -2.78 | -5.294 | -4.47 | -5.258 |
| Gross Profit Ratio
| 0.343 | 0.357 | 0.292 | 0.253 | 0.236 | 0.214 | 0.192 | 0.165 | 0.156 | 0.151 | 0.145 | 0.118 | 0.112 | 0.042 | 0.013 | 0.024 | -0.373 | -0.406 | -0.496 | -0.392 | -2.013 | -1.556 | -2.111 |
| Reseach & Development Expenses
| 8.139 | 9.734 | 12.635 | 12.532 | 16.076 | 14.906 | 13.793 | 11.444 | 13.059 | 13.521 | 10.831 | 11.41 | 9.729 | 8.032 | 7.57 | 7.784 | 9.175 | 6.053 | 5.838 | 6.629 | 5.708 | 5.583 | 5.407 |
| General & Administrative Expenses
| 10.103 | 12.684 | 11.444 | 10.339 | 11.815 | 11.29 | 11.787 | 10.022 | 10 | 10.784 | 9.709 | 9.719 | 7.629 | 9.722 | 9.246 | 9.05 | 13.088 | 4.848 | 3.526 | 2.278 | 2.439 | 2.186 | 2.016 |
| Selling & Marketing Expenses
| 15.417 | 18.128 | 21.048 | 22.194 | 24.72 | 24.985 | 24.333 | 23.631 | 22.276 | 23.198 | 20.377 | 22.991 | 15.726 | 13.204 | 13.149 | 15.198 | 13.344 | 9.244 | 7.282 | 6.883 | 5.009 | 4.51 | 3.857 |
| SG&A
| 25.52 | 30.812 | 32.492 | 32.533 | 36.535 | 36.275 | 36.12 | 33.653 | 32.276 | 33.982 | 30.086 | 32.71 | 23.355 | 22.926 | 22.395 | 24.248 | 26.432 | 14.092 | 10.808 | 9.161 | 7.448 | 6.696 | 5.873 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 33.659 | 40.546 | 45.127 | 45.065 | 52.611 | 51.181 | 49.913 | 45.097 | 45.335 | 47.503 | 40.917 | 44.12 | 33.084 | 30.958 | 29.965 | 32.032 | 35.607 | 20.145 | 16.646 | 15.79 | 13.156 | 12.229 | 10.846 |
| Operating Income
| -23.839 | -30.764 | -36.912 | -37.353 | -45.454 | -43.478 | -43.485 | -39.824 | -40.999 | -43.721 | -36.475 | -40.799 | -30.138 | -29.906 | -29.676 | -31.615 | -40.733 | -24.909 | -20.21 | -18.57 | -18.45 | -16.749 | -16.538 |
| Operating Income Ratio
| -0.832 | -1.123 | -1.31 | -1.224 | -1.497 | -1.206 | -1.299 | -1.244 | -1.477 | -1.745 | -1.194 | -1.449 | -1.145 | -1.186 | -1.295 | -1.833 | -2.961 | -2.121 | -2.811 | -2.621 | -7.015 | -5.832 | -6.639 |
| Total Other Income Expenses Net
| -3.919 | -3.539 | -2.87 | -1.135 | -0.64 | -0.435 | -0.294 | -1.556 | 0.238 | -0.022 | -0.302 | -0.308 | -0.332 | -0.267 | -0.31 | -0.428 | -1.561 | -1.596 | -0.44 | -0.876 | 3.068 | -0.28 | 0.116 |
| Income Before Tax
| -27.758 | -34.303 | -39.782 | -38.488 | -46.094 | -43.913 | -43.779 | -41.38 | -40.761 | -43.743 | -36.777 | -41.107 | -30.47 | -30.173 | -29.986 | -32.043 | -42.294 | -26.505 | -20.65 | -19.446 | -15.382 | -17.029 | -16.422 |
| Income Before Tax Ratio
| -0.968 | -1.252 | -1.412 | -1.262 | -1.518 | -1.218 | -1.308 | -1.293 | -1.468 | -1.746 | -1.204 | -1.46 | -1.158 | -1.197 | -1.309 | -1.858 | -3.075 | -2.257 | -2.872 | -2.745 | -5.849 | -5.929 | -6.593 |
| Income Tax Expense
| 0.182 | 0.151 | 0.162 | 0.112 | 0.086 | 0.133 | 0.192 | 0.064 | 0.02 | 0.096 | 0.115 | 0.125 | -1.214 | 0.035 | 0.039 | -1.93 | 0.431 | 1.032 | 1.001 | 1.02 | 0.02 | 8.028 | 7.87 |
| Net Income
| -27.94 | -34.454 | -39.944 | -38.6 | -46.18 | -44.046 | -43.971 | -41.444 | -40.781 | -43.839 | -36.892 | -41.232 | -30.47 | -30.208 | -30.025 | -32.043 | -42.294 | -26.505 | -20.65 | -19.446 | -15.402 | -25.057 | -24.292 |
| Net Income Ratio
| -0.975 | -1.258 | -1.418 | -1.265 | -1.521 | -1.222 | -1.314 | -1.295 | -1.469 | -1.75 | -1.208 | -1.465 | -1.158 | -1.198 | -1.31 | -1.858 | -3.075 | -2.257 | -2.872 | -2.745 | -5.856 | -8.725 | -9.752 |
| EPS
| -0.55 | -0.66 | -0.78 | -0.77 | -0.93 | -0.9 | -0.9 | -0.86 | -0.85 | -0.92 | -0.78 | -0.88 | -0.65 | -0.66 | -0.7 | -0.75 | -3.44 | -0.67 | -0.69 | -0.65 | -0.51 | -30.17 | -30.27 |
| EPS Diluted
| -0.55 | -0.66 | -0.78 | -0.77 | -0.93 | -0.9 | -0.9 | -0.86 | -0.85 | -0.92 | -0.78 | -0.87 | -0.65 | -0.66 | -0.7 | -0.75 | -3.44 | -0.67 | -0.69 | -0.65 | -0.51 | -30.16 | -30.27 |
| EBITDA
| -21.69 | -26.822 | -32.354 | -33.625 | -41.099 | -38.988 | -39.158 | -37.727 | -38.598 | -41.663 | -35.093 | -39.117 | -28.726 | -28.435 | -28.318 | -29.685 | -41.082 | -24.982 | -19.344 | -17.94 | -13.868 | -16.373 | -16.158 |
| EBITDA Ratio
| -0.757 | -1.07 | -1.259 | -1.102 | -1.412 | -1.132 | -1.22 | -1.185 | -1.448 | -1.727 | -1.149 | -1.445 | -1.141 | -1.128 | -1.236 | -1.833 | -2.93 | -2.074 | -2.704 | -2.452 | -6.749 | -5.701 | -6.487 |